Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Current Taxes (2024 - 2025)

Historic Current Taxes for Adma Biologics (ADMA) over the last 2 years, with Q3 2025 value amounting to $2.8 million.

  • Adma Biologics' Current Taxes changed N/A to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year change of. This contributed to the annual value of $3.5 million for FY2024, which is N/A changed from last year.
  • Adma Biologics' Current Taxes amounted to $2.8 million in Q3 2025.
  • Adma Biologics' Current Taxes' 5-year high stood at $6.6 million during Q1 2025, with a 5-year trough of $2.7 million in Q2 2025.